Literature DB >> 15785061

Cutaneous leishmaniasis caused by Leishmania tropica: treatment with oral fluconazole.

E Laffitte, B Genton, R G Panizzon.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15785061     DOI： 10.1159/000083797

Source DB:  PubMed          Journal:  Dermatology        ISSN： 1018-8665            Impact factor:   5.366


× No keyword cloud information.
  4 in total

1.  Comparative study of the efficacy of formulations containing fluconazole or paromomycin for topical treatment of infections by Leishmania (Leishmania) major and Leishmania (Leishmania) amazonensis.

Authors:  Samuel Vidal Mussi; Ana Paula Fernandes; Lucas Antonio Miranda Ferreira
Journal:  Parasitol Res       Date:  2007-01-06       Impact factor: 2.289

2.  Study of in vitro drug release and percutaneous absorption of fluconazole from topical dosage forms.

Authors:  Claudia Salerno; Adriana M Carlucci; Carlos Bregni
Journal:  AAPS PharmSciTech       Date:  2010-06-03       Impact factor: 3.246

3.  Voriconazole suppresses the growth of Leishmania species in vitro.

Authors:  Manjusha M Kulkarni; Niveditha Reddy; Tulasi Gude; Bradford S McGwire
Journal:  Parasitol Res       Date:  2013-02-08       Impact factor: 2.289

Review 4.  Determinants of Unresponsiveness to Treatment in Cutaneous Leishmaniasis: A Focus on Anthroponotic Form Due to Leishmania tropica.

Authors:  Mehdi Bamorovat; Iraj Sharifi; Razieh Tavakoli Oliaee; Abdollah Jafarzadeh; Ahmad Khosravi
Journal:  Front Microbiol       Date:  2021-06-01       Impact factor: 5.640
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.